Alamar Biosciences IPO Raises $219.9M for Blood-Based Biomarker Tools
Alamar Biosciences closed an upsized IPO, raising $219.9 million by pricing 12.9 million shares at $17 each, and began trading on Nasdaq under the ticker ALMR. The California‑based firm offers the NULISA platform, which detects low‑level protein biomarkers in blood, and its ARGO HT instrument automates high‑plex proteomic analysis for research use. Current assay panels focus on neurology and immunology, including Alzheimer’s‑related markers, while a diagnostic version, ARGO HT/DX, is slated for FDA submission in 2027. The capital raise positions Alamar to expand its product suite and market reach.
Kailera Therapeutics IPO Raises $718.8M for Obesity Drug Pipeline
Kailera Therapeutics completed a $718.8 million IPO, pricing 44.9 million shares at $16 each and listing on Nasdaq under KLRA. The company’s lead candidate, ribupatide, is a once‑weekly injectable GLP‑1/GIP dual agonist currently in three global Phase III trials targeting obesity and type 2...
Importing Rapamycin to Save Money (2)
A community member placed a test order for sirolimus tablets from RL Pharma Jagdish in India via IndiaMart.com, paying a $25 wire transfer. The package left on Oct 16 2025 and arrived after 26 days on Nov 10 2025, experiencing delays in Zurich, JFK customs,...
A Popular Senolytic Treatment Causes Brain Damage in Mice
A recent PNAS study shows that the widely used senolytic cocktail dasatinib plus quercetin (D+Q) impairs myelination in the mouse corpus callosum. The treatment altered oligodendrocyte morphology within minutes, reduced myelin thickness, and triggered endoplasmic reticulum stress, without killing the...
CDR vs ACDF in the Back to Work Sweepstakes. Who Wins?
A new meta‑analysis of 16 randomized trials involving more than 5,600 patients compares anterior cervical discectomy and fusion (ACDF) with cervical disc replacement (CDR). The data show CDR patients return to work significantly faster – 33% more likely at six...
With Cell and Gene Therapies Proliferation, Specialty Pharmacy Faces New Pricing, Distribution Pressures
Cell and gene therapies are moving from ultra‑rare indications to broader patient populations, prompting a fundamental redesign of specialty‑pharmacy distribution and pricing models. At the 2026 Asembia meeting, experts warned that current flash‑title and buy‑and‑bill channels may not scale to...
Pharmaceutical Executive Daily: FDA Approves Breztri
Sun Pharmaceutical Industries agreed to buy Organon for $11.75 billion, propelling the combined entity into the top‑25 global pharma ranks. IMG Pharmaceutical announced the acquisition of Japan’s Matsumoto Pharmaceutical, adding a portfolio with more than 50 OTC approvals. The FDA granted...
Breaking: Fauci’s Top Advisor Charged in COVID Cover-Up Case
David Morens, a longtime senior advisor to Dr. Anthony Fauci, was indicted by the Department of Justice on charges of conspiracy and destruction of federal records. Prosecutors allege he used private email accounts to move COVID‑related discussions off official systems,...
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
At the Asembia AXS26 Summit, Clarivate’s Dee Chaudhary warned that U.S. drug‑pricing policy is moving from theory to real‑time execution, reshaping payer behavior and market volatility. The Inflation Reduction Act’s Medicare price negotiations, the new One Big, Beautiful Bill Act, and renewed Most Favored...
What’s the Actual Neurological Cost of a 3-Column Osteotomy?
A prospective multicenter study of 553 adult spinal deformity patients found that 130 (23.5%) underwent a three‑column osteotomy (3CO). Neurologic adverse events occurred in 23.1% of 3CO cases versus 15.4% without a 3CO, a statistically significant increase. Despite the higher...
Profluent and Lilly: The Next Gene Editor Will Be Designed by AI
Profluent, an Air Street Capital portfolio company, announced a multi‑program partnership with Eli Lilly to create AI‑designed recombinases for kilobase‑scale gene editing. The deal includes an upfront cash payment, committed R&D funding, and up to $2.25 billion in development and commercial milestones...
The Persistent Misleading Claim That Vaccines Aren’t Properly Tested for Safety
FactCheck.org debunks the persistent anti‑vaccine claim that childhood vaccines lack proper safety testing. The article explains that vaccine trials employ active comparators and extensive phase III studies, gathering safety data from millions of doses before approval. It also highlights ongoing post‑marketing...
VSRF LIVE TONIGHT: Episode 225: Vaccine Injured: A Path to Recovery
VSRF Live’s Episode 225 aired three personal accounts of alleged COVID‑19 vaccine injuries and highlighted emerging recovery paths, including self‑directed research, experimental therapies, and overseas plasma filtration. The broadcast also promoted a petition to repeal the 1986 vaccine liability shield, urging...
Obesity’s Effects on the Immune System May Linger for Years
A European study shows that helper CD4+ T cells retain a pro‑inflammatory effector‑memory phenotype long after mice regain normal weight following obesity. While adipose mass normalizes, the inflammatory T‑cell response persists for weeks and only resolves after extended weight‑maintenance periods....
New York Proposes an Additional Layer of Legal Protection to Those Profiting From Injecting Vaccines
New York is introducing Senate Bill A9140, which would grant blanket legal immunity to doctors, pharmacists and other entities that prescribe, dispense, order, furnish, or administer vaccines to minors. The bill bars any civil lawsuit alleging injury, including residual effects,...
How High Pressure Destroys Relational Care in Nursing
Megan Diaz, a veteran RN, argues that relentless pressure in hospitals narrows nurses' perceptual range, eroding relational care. As bed turnover and discharge speed become primary metrics, clinicians resort to labeling patients rather than exploring underlying context. This shift sacrifices nuanced...
Ludi Announces Ludi Boost™: New AI-Powered Operating Model & Strategic Services Offering for Provider Workforce Management
Ludi, Inc. unveiled Ludi Boost™, an AI‑enabled compensation platform that bundles advanced technology with a strategic services team of more than 80 experts. The solution consolidates compensation data, governance and administration into a single system of record, promising faster program execution,...
Ashvattha Therapeutics Announces Presentations Highlighting Mechanism of Action for Migaldendranib in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Ashvattha Therapeutics presented Phase 2 data on its subcutaneous nanomedicine migaldendranib (MGB) for diabetic macular edema and neovascular age‑related macular degeneration at ARVO. The two‑stage trial showed stable central subfield thickness for up to 12 weeks and maintained visual acuity without...
AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
AtriCure announced it will take part in the 2026 Bank of America Securities Health Care Conference, with senior management slated for a fireside chat on May 12, 2026. The session will be streamed live via the company’s investor website, giving...
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-Cel
Cellares has entered a 10‑year commercial supply agreement with Cabaletta Bio to manufacture rese‑cel, the company’s autologous CAR‑T therapy for autoimmune diseases, using its fully automated Cell Shuttle and Cell Q platforms. The deal secures long‑term capacity to produce thousands of...
A Collective Cognitive Dissonance
The author challenges the common refrain that every Epic electronic‑health‑record (EHR) instance is fundamentally different, arguing that the real source of variation lies in the hospitals’ unique workflows, staffing, and local policies rather than the software itself. While customization is...
Availity Introduces Availity Extend to Secure Healthcare Automation at Scale
Availity, the nation’s largest healthcare network, launched Availity Extend, a platform that lets payers, providers, and tech partners build automation and AI directly on its network. The solution leverages Availity’s existing connectivity and security framework, enabling workflows to run with live...
Superior Health Holdings Acquires Compassion Homecare and Sans Bois Hospice, Expanding Into Oklahoma
Superior Health Holdings, backed by Renovus Capital Partners, announced the acquisition of Chant Healthcare, the operator of Compassion Home Care and Sans Bois Hospice in southeastern Oklahoma. The deal gives Superior an immediate footprint across 11 counties, adding home health, hospice,...
Provider Data Management - A Niche but Important Problem | Out-Of-Pocket
CertifyOS tackles the chronic problem of inaccurate provider directories by aggregating data from rosters, CAQH, NPPES, state boards and the providers themselves into a unified, AI‑enhanced golden record. The platform normalizes disparate feeds, tracks changes with audit logs, and offers...
Sensitive Data as Venn Diagram
Healthcare data is split into "Normal" (non‑sensitive) and "Restricted" (sensitive) categories. Sensitive records receive specific sensitivity codes in the FHIR Resource.meta.security tag, creating a Venn diagram of overlapping topics such as Sexual Health, Mental Health, and Substance Use. The tags...
Drug Pricing, PBM Reform, and the 2026 Midterms: What You Need to Know
Analysts at Avalere Health’s AXS26 summit warned that the 2026 midterm elections will reshape drug pricing and PBM practices. Recent FTC settlements require Express Scripts, CVS Caremark and Optum Rx to end spread pricing and unlink compensation from rebates, while...
FDA Approves Breztri for Patients 12 Years and Older with Asthma
The FDA has approved Breztri Aerosphere, a single‑inhaler triple‑combination of budesonide, glycopyrrolate, and formoterol, for maintenance treatment of asthma in patients aged 12 and older. This marks the first U.S. approval of a triple therapy that adds a long‑acting muscarinic...
Improving Health Literacy Requires Dual Efforts
Poor health literacy, especially among older adults, remains widespread, prompting federal action. The Office of Disease Prevention and Health Promotion’s National Action Plan and the CDC’s health‑literacy toolkit outline clear‑communication principles for providers and actionable guidance for patients. Experts recommend...
Tennessee Revolts Against Pharmacy Middlemen
Tennessee lawmakers passed the FAIR Rx Act, requiring pharmacy benefit managers (PBMs) to divest any pharmacies they own, directly targeting the vertical‑integration model of giants like CVS Health. The bipartisan vote was overwhelming—86‑7 in the House and 24‑9 in the...
Why Kennedy’s Addiction Treatment Plan Raises Ethical Concerns
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is pushing a U.S. version of Italy’s Patrignano program, which pairs addiction recovery with unpaid labor. Patrignano reports high self‑reported recovery after three years, yet one‑fifth of residents quit within a year citing...
Qp:Qs Explained: Quantifying Hemodynamic Significance in Shunt Lesions
The article explains how to calculate the pulmonary‑to‑systemic flow ratio (Qp:Qs) using four standard Doppler measurements, turning a visual guess into a quantitative decision tool. It outlines clinical thresholds that separate observation from intervention for atrial septal defects, ventricular septal...
This Is How Crazy Judge Murphy’s Ruling on CDC Vaccine Schedule Really Is
Federal Judge Brian Murphy has issued a sweeping order that freezes any modifications to the Centers for Disease Control and Prevention’s vaccine schedule. The ruling ties future changes to the appointment of new advisory committee members, who must be selected...
Why Mental Health Care in Nigeria Needs a New Approach
Nigeria’s mental‑health crisis is hidden behind physical complaints such as headaches, fatigue and gastrointestinal issues, as cultural stigma labels emotional distress as weakness or spiritual attack. With fewer than one psychiatrist per 100,000 people, most specialists are confined to urban...
CT Governor Signs Bill Protecting State Vaccine Access From Federal Rollback
Connecticut Governor Ned Lamont signed House Bill 5044, a law that separates the state’s immunization standards from the federal Advisory Committee on Immunization Practices (ACIP). The legislation preserves pharmacists’ authority to administer vaccines, mandates that insurers continue covering vaccine costs,...
Asembia's AXS26 Summit: How Is Digital Innovation Transforming Programs for Patient Access?
At Assembia’s AXS26 Summit, Syneos Health’s VP Kim Plesnarski explained how digital tools—wearables, sensors, smart pills—are reshaping patient access programs by feeding real‑time data into EMRs and clinician workflows. She emphasized that integrating these solutions early is critical to personalize...
Award-Winning Care Provider Opens 27-Bed Residential Home
Thornton Hill Care Home, a 27‑bed boutique residential facility, opened near Skipton after a full redevelopment of a restored 1870s manor. The luxury‑focused home offers independent living with daily support, targeting individuals and couples seeking a community‑centric environment. Managed by...
How to Get Pfizer & Moderna mRNA Out of Your Body
The article explains that Pfizer‑BioNTech and Moderna COVID‑19 vaccines rely on lipid‑nanoparticle‑encapsulated synthetic mRNA that is chemically altered with N1‑methylpseudouridine. This modification cloaks the RNA from innate immune sensors and dramatically slows enzymatic breakdown, extending its intracellular lifespan. Consequently, the...
How Pediatricians Are Navigating America’s Surge of Health Misinformation
Pediatricians across the United States are confronting a sharp rise in vaccine misinformation that has been amplified by the Covid‑19 pandemic and high‑profile political figures. Anti‑vaccine sentiment, once marginal, now enjoys mainstream visibility, with Health Secretary Robert F. Kennedy Jr....
428. I Have Arranged to Get You Unbekoming's Complete New DMSO Book for Free.
The author of Surviving Healthcare has secured a free PDF of Unbekoming’s comprehensive DMSO book and is distributing it to his readership. Unbekoming, an Australian Substack writer, normally locks the 15‑book health library behind a paid subscription, but a limited‑time...
How Personalizing Nutrition Can Manage Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) affects roughly 2.4‑3.1 million Americans and costs the U.S. economy about $50 billion each year. New research highlights that the typical Western diet—rich in refined sugars, vegetable oils, and ultra‑processed foods—disrupts the gut microbiome, increases intestinal permeability, and...
Today’s Neurology Science Briefing
A recent BMJ Neurology brief highlights robust evidence that subthalamic deep brain stimulation (DBS) offers measurable motor benefits for patients with symmetric Parkinson's disease, giving clinicians clearer risk‑benefit guidance. The study’s real‑world data strengthens counseling on DBS candidacy and expected...
Today’s Public Health Science Briefing
Recent research published in The Lancet Diabetes & Endocrinology finds that men with diabetes who maintain low levels of visceral fat face a markedly lower risk of developing diabetic kidney disease. The study highlights that relying solely on Body Mass...
What If Endometriosis Is Not Just Hormonal? Scientists Are Looking at Bacteria
Endometriosis, long explained by retrograde menstruation, is now being re‑examined through a bacterial lens. A 2023 iScience review highlights that 64% of patients harbor Fusobacterium in the endometrium, suggesting microbes may trigger inflammation via LPS‑TLR4 signaling and facilitate lesion formation....
When Joe Rogan Is in Charge of Health Care
President Donald Trump signed an executive order that accelerates research funding and fast‑track FDA review for psychedelic therapies after podcaster Joe Rogan texted the president about their potential. The order directs the Department of Health and Human Services to boost...
Monday April 27, 2026
Policy and market forces converged this week as CMS and the FDA launched the RAPID coverage pathway, slashing Medicare approval timelines for breakthrough devices from over a year to as little as two months for roughly 40 qualifying products. Meanwhile,...
WARNING: UK Could Face Repeat Lockdowns Using the Same Pandemic Playbook
A former World Health Organization scientist, David Bell, warned that the draft WHO pandemic treaty could push the United Kingdom back into Covid‑era lockdowns, mask mandates and mass vaccination campaigns. The treaty, slated for final negotiations in Geneva, expands surveillance,...
The Coming War over the NDIS
Australian Health Minister Mark Butler announced a package of reforms to the National Disability Insurance Scheme (NDIS) aimed at capping program spending at roughly $55 billion AUD (≈$36 billion USD) by year‑end. The changes are projected to save about $22 billion AUD (≈$14.5 billion...
Bridging the Gap in Neurodevelopmental Care and Pediatrics
Dr. Ronald L. Lindsay reflects on decades of effort to connect developmental‑behavioral pediatrics with neurodevelopmental disability services, noting both successes—such as the LEND program, JBLM‑CARES, and the NIMH‑RUPP Autism Network expansion—and persistent institutional resistance. He explains that many bridges collapsed...
CRP: What It Can, and Can't, Tell You
High‑sensitivity C‑reactive protein (hsCRP) is an inflammation marker used to refine cardiovascular risk assessment. The 2025 ACC scientific statement recommends a one‑time baseline hsCRP measurement, with values 3 mg/L high risk. Clinical trials such as JUPITER demonstrated that statin therapy reduces...
Overcoming Barriers to Holding Babies with Hypoxic-Ischemic Encephalopathy During Therapeutic Cooling
Therapeutic hypothermia remains the standard treatment for newborns with hypoxic‑ischemic encephalopathy (HIE), but most NICUs prohibit parental holding during the 72‑hour cooling period. Recent, albeit small, studies show that holding does not cause temperature instability or vital‑sign changes, yet an...